Search

everythinglearnresearchcommunity

for

Search:↓

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Reduced matriptase activity causes skin and hair issues in both humans and mice.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

A new mutation in the HJV gene was found in a young woman with juvenile hemochromatosis, causing unusual symptoms like secondary hypothyroidism.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Imatinib can cause hair loss due to lichen planopilaris.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Monilethrix is linked to the type II keratin gene on chromosome 12q13.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Hidradenitis suppurativa may be more severe in people with Mediterranean fever gene mutations.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.